U.S. federal trademark · Serial No. 90590474 · Reg. No. 7754868
Research and development of pharmaceuticals, namely, small molecule therapies for the alteration of RNA splicing and expression, used in the treatment of cancers, neurological diseases, infectious diseases and other diseases using integrated and high-throughput screening technologies coupled with next-generation sequencing
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.